Curis (CRIS) Non Operating Investment Income (2010 - 2013)
Curis (CRIS) reported Non Operating Investment Income of -$1.1 million for Q3 2013, down 169.57% on a YoY basis from $1.5 million in Q3 2012, and down 421.99% quarter-over-quarter from $333141.0 in Q2 2013.
Curis (CRIS) Non Operating Investment Income (2010 - 2013) Analysis & Trends
Curis has reported Non Operating Investment Income for 4 years, with the latest figure at -$1.1 million in Q3 2013.
- For the quarter ending Q3 2013, Non Operating Investment Income fell 169.57% year-over-year to -$1.1 million; the trailing twelve-month figure through Sep 2013 stood at $306892.0 (up 165.66% YoY), and the FY2011 full-year result was -$2.8 million, down 578.7% from the prior year.
- Non Operating Investment Income for Q3 2013 stood at -$1.1 million, down from $333141.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $1.5 million in Q3 2012, with the low at -$1.5 million in Q4 2011.
- Historically, Non Operating Investment Income has averaged -$137620.7 across 4 years, with a median of $23865.5 in 2010.
- The largest YoY upside for Non Operating Investment Income was 182.98% in 2011 against a maximum downside of 905.33% in 2011.
- Curis' Non Operating Investment Income stood at $542855.0 in 2010, then plunged by 380.33% to -$1.5 million in 2011, then jumped by 201.32% to $1.5 million in 2012, then slumped by 169.57% to -$1.1 million in 2013.
- The last three Non Operating Investment Income figures came in at -$1.1 million (Q3 2013), $333141.0 (Q2 2013), and $1.5 million (Q3 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 230,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Curis | 8.27 Mn | -6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | -1.07 Mn |
| Sep 30, 2013 | -1.07 Mn |
| Jun 30, 2013 | 333,141.00 |
| Jun 30, 2013 | 333,141.00 |
| Sep 30, 2012 | 1.54 Mn |
| Sep 30, 2012 | 1.54 Mn |
| Jun 30, 2012 | -495,341.00 |
| Jun 30, 2012 | -495,341.00 |
| Mar 31, 2012 | 7,941.00 |
| Mar 31, 2012 | 7,941.00 |
| Dec 31, 2011 | -1.52 Mn |
| Dec 31, 2011 | -1.52 Mn |
| Sep 30, 2011 | 587,184.00 |
| Sep 30, 2011 | 587,184.00 |
| Jun 30, 2011 | -320,440.00 |
| Jun 30, 2011 | -320,440.00 |
| Mar 31, 2011 | -1.50 Mn |
| Mar 31, 2011 | -1.50 Mn |
| Dec 31, 2010 | 542,855.00 |
| Dec 31, 2010 | 542,855.00 |